Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Karuna Therapeutics (KRTX) stocks in Canada
Learn how to easily invest in Karuna Therapeutics stocks.
Karuna Therapeutics is a biotechnology business based in the US. Karuna Therapeutics stocks (KRTX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $120.04 – a decrease of 0.6% over the previous week. Karuna Therapeutics employs 63 staff and has a market cap (total outstanding stock value) of $3.4 billion.
How to buy shares in Karuna Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KRTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Karuna Therapeutics?
- Has coronavirus impacted Karuna Therapeutics shares?
- Karuna Therapeutics shares summary
- Compare share dealing platforms
- Is Karuna Therapeutics stock a buy or sell?
- Karuna Therapeutics performance over time
- Karuna Therapeutics's financials
- How volatile are Karuna Therapeutics shares?
- Does Karuna Therapeutics pay a dividend?
- Other common questions
Karuna Therapeutics stock price (NASDAQ:KRTX)Use our graph to track the performance of KRTX stocks over time.
Karuna Therapeutics shares at a glance
|Latest market close||$112.00|
|52-week range||$94.90 - $161.98|
|50-day moving average||$125.24|
|200-day moving average||$120.64|
|Wall St. target price||$175.07|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.92|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Karuna Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Karuna Therapeutics price performance over time
|1 week (2022-01-20)||0.22%|
|1 month (2021-12-23)||-16.12%|
|3 months (2021-10-27)||-16.41%|
|6 months (2021-07-27)||0.83%|
|1 year (2021-01-27)||17.33%|
|2 years (2020-01-24)||12.28%|
|3 years (2019-01-23)||N/A|
|5 years (2017-01-23)||N/A|
Karuna Therapeutics financials
|Gross profit TTM||$0|
|Return on assets TTM||-19.06%|
|Return on equity TTM||-31.95%|
|Market capitalisation||$3.4 billion|
TTM: trailing 12 months
Karuna Therapeutics share dividends
We're not expecting Karuna Therapeutics to pay a dividend over the next 12 months.
Karuna Therapeutics share price volatility
Over the last 12 months, Karuna Therapeutics's shares have ranged in value from as little as $94.9 up to $161.98. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Karuna Therapeutics's is 1.7212. This would suggest that Karuna Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Karuna Therapeutics overview
Karuna Therapeutics, Inc. , a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that has completed Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia; and in Phase Ib clinical trial for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc.
Stocks similar to Karuna Therapeutics
Karuna Therapeutics in the news
Stocks making the biggest moves in the premarket: Kohl's, Snap, Peloton and more
Earnings playbook: A complete guide to this week's reports, including the first of tech
Markets are expected to remain on edge as the Fed meets in the week ahead
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
GreenTrust (GNT) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy GreenTrust, lists some exchanges where you can get it and provides daily price data on GNT.
Ask an Expert
You must be logged in to post a comment.